Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery
暂无分享,去创建一个
[1] David H. Hall,et al. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34 , 2001, Neurobiology of Aging.
[2] R. Köster,et al. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). , 2009, Brain : a journal of neurology.
[3] Craig Montell,et al. The TRP Superfamily of Cation Channels , 2005, Science's STKE.
[4] L. Chinn,et al. Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms in Drosophila , 2009, The Journal of Neuroscience.
[5] W. Harris,et al. Conditioned behavior in Drosophila melanogaster. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[7] D. Campion,et al. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. , 2007, Human molecular genetics.
[8] Kyunghee Koh,et al. A Drosophila model for age-associated changes in sleep:wake cycles , 2006, Proceedings of the National Academy of Sciences.
[9] B. Oostra,et al. DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism , 2003, Neurological Sciences.
[10] E. Kravitz,et al. Targeted Manipulation of Serotonergic Neurotransmission Affects the Escalation of Aggression in Adult Male Drosophila melanogaster , 2010, PloS one.
[11] Stephen M. Mount,et al. The genome sequence of Drosophila melanogaster. , 2000, Science.
[12] S. Benzer,et al. From the gene to behavior. , 1971, JAMA.
[13] C. Link,et al. What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases? , 2009, Molecular Neurodegeneration.
[14] U. Banerjee,et al. The little R cell that could. , 2004, International Journal of Developmental Biology.
[15] A. Gitler,et al. Discovery and characterization of three novel synuclein genes in zebrafish , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.
[16] B. Lu,et al. PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila , 2004, Cell.
[17] B. E. Staveley,et al. parkin counteracts symptoms in a Drosophila model of Parkinson's disease , 2004, BMC Neuroscience.
[18] E. Hafen,et al. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos , 1993, Cell.
[19] Y. Yan,et al. A comparative map of the zebrafish genome. , 2000, Genome research.
[20] A. Ramasamy,et al. Drosophila-based in vivo assay for the validation of inhibitors of the epidermal growth factor receptor/Ras pathway , 2008, Journal of Biosciences.
[21] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. , 1996, Lancet.
[22] K. Siwicki,et al. Drosophila Lacking dfmr1 Activity Show Defects in Circadian Output and Fail to Maintain Courtship Interest , 2002, Neuron.
[23] D. Featherstone,et al. A glial amino-acid transporter controls synapse strength and courtship in Drosophila , 2008, Nature Neuroscience.
[24] P. Jin,et al. RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTAS , 2007, Neuron.
[25] J. Taylor,et al. HDAC6 at the Intersection of Autophagy, the Ubiquitin-proteasome System, and Neurodegeneration , 2007, Autophagy.
[26] B. Stockwell,et al. Biologically active molecules that reduce polyglutamine aggregation and toxicity. , 2006, Human molecular genetics.
[27] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[28] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[29] C. Thummel,et al. Diabetic larvae and obese flies-emerging studies of metabolism in Drosophila. , 2007, Cell metabolism.
[30] M. Scott,et al. A nucleostemin family GTPase, NS3, acts in serotonergic neurons to regulate insulin signaling and control body size. , 2008, Genes & development.
[31] James E Bear,et al. A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Goodwin,et al. Compartmentalization of neuronal and peripheral serotonin synthesis in Drosophila melanogaster , 2007, Genes, brain, and behavior.
[33] Todd A. Clason,et al. Permeabilization of Drosophila embryos for introduction of small molecules. , 2010, Insect biochemistry and molecular biology.
[34] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[35] Dan Garza,et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS , 2007, Nature.
[36] Robin L Cooper,et al. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster , 2007, The European journal of neuroscience.
[37] J. Littleton,et al. Development of a Drosophila seizure model for in vivo high‐throughput drug screening , 2006, The European journal of neuroscience.
[38] Daniela C. Zarnescu,et al. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. , 2008, Nature chemical biology.
[39] Giulio Tononi,et al. Reduced sleep in Drosophila Shaker mutants , 2005, Nature.
[40] C. Nichols,et al. Identification of neuroprotective compounds of Caenorhabditis elegans dopaminergic neurons against 6-OHDA , 2007, Journal of Molecular Neuroscience.
[41] M. Tanouye,et al. Modifications of seizure susceptibility in Drosophila. , 2000, Journal of neurophysiology.
[42] Bin Zhang,et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] Aaron T. Haselton,et al. Adult Drosophila melanogaster as a model for the study of glucose homeostasis , 2010, Aging.
[44] R. Greenspan,et al. Drosophila D1 dopamine receptor mediates caffeine-induced arousal , 2008, Proceedings of the National Academy of Sciences.
[45] K. Raley-Susman,et al. The invertebrate microtubule-associated protein PTL-1 functions in mechanosensation and development in Caenorhabditis elegans , 2008, Development Genes and Evolution.
[46] John Q. Trojanowski,et al. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.
[47] K. Ocorr,et al. Drug discovery through functional screening in the Drosophila heart. , 2009, Methods in molecular biology.
[48] D. O'Dowd,et al. Cholinergic Synaptic Transmission in Adult Drosophila Kenyon Cells In Situ , 2006, The Journal of Neuroscience.
[49] K. Wada,et al. [The ubiquitin-proteasome system and neurodegeneration]. , 2001, Rinsho shinkeigaku = Clinical neurology.
[50] Tsonwin Hai,et al. Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly , 2008, Molecular Psychiatry.
[51] Jian Feng,et al. Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation , 2003, The Journal of Neuroscience.
[52] A. Spada,et al. Polyglutamines Placed into Context , 2003, Neuron.
[53] Alfonso Martinez Arias,et al. Drosophila melanogaster and the development of biology in the 20th century. , 2008, Methods in molecular biology.
[54] P. Pollak,et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.
[55] Y. Chernoff,et al. Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1 , 2002, The Journal of cell biology.
[56] M. Tanouye,et al. Seizures and failures in the giant fiber pathway of Drosophila bang- sensitive paralytic mutants , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[57] Y. Jan,et al. Multiple potassium–channel components are produced by alternative splicing at the Shaker locus in Drosophila , 1988, Nature.
[58] Serotonin and insulin signaling team up to control growth in Drosophila. , 2008, Genes & development.
[59] S. Hayashi,et al. A nuclear GFP/β‐galactosidase fusion protein as a marker for morphogenesis in living Drosophila , 1996 .
[60] F. Casares,et al. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia. , 2006, Human molecular genetics.
[61] A Dürr,et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.
[62] Jin Man Kim,et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] Ronald L. Davis,et al. GABAA Receptor RDL Inhibits Drosophila Olfactory Associative Learning , 2007, Neuron.
[64] Ronald L. Davis,et al. Olfactory memory formation in Drosophila: from molecular to systems neuroscience. , 2005, Annual review of neuroscience.
[65] George R Jackson,et al. A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine , 2007, The Journal of Neuroscience.
[66] K. Lim,et al. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. , 2007, Human molecular genetics.
[67] M. Jafari,et al. Lamotrigine extends lifespan but compromises health span in Drosophila melanogaster , 2009, Biogerontology.
[68] Thomas N. Sato,et al. On the Mechanics of Cardiac Function of Drosophila Embryo , 2008, PloS one.
[69] A. Guo,et al. Study of tauopathies by comparing Drosophila and human tau in Drosophila , 2007, Cell and Tissue Research.
[70] R. Nass,et al. The Divalent Metal Transporter Homologues SMF-1/2 Mediate Dopamine Neuron Sensitivity in Caenorhabditis elegans Models of Manganism and Parkinson Disease* , 2009, The Journal of Biological Chemistry.
[71] Ronald L. Davis,et al. P{Switch}, a system for spatial and temporal control of gene expression in Drosophila melanogaster , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[72] P. Evans,et al. Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors , 2005, Invertebrate Neuroscience.
[73] Michael Lardelli,et al. Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. , 2006, Human molecular genetics.
[74] Andrew Smith. Genome sequence of the nematode C-elegans: A platform for investigating biology , 1998 .
[75] V. Lee,et al. Are Ubiquitination Pathways Central to Parkinson's Disease? , 2003, Cell.
[76] Leo X. Liu,et al. Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of α-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans* , 2005, Journal of Biological Chemistry.
[77] T. Iwatsubo,et al. Familial Parkinson Mutant α-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans* , 2006, Journal of Biological Chemistry.
[78] Songsong Cao,et al. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model , 2008, Proceedings of the National Academy of Sciences.
[79] D. Nässel,et al. Drosophila neuropeptides in regulation of physiology and behavior , 2010, Progress in Neurobiology.
[80] Robin L. Cooper,et al. Direct influence of serotonin on the larval heart of Drosophila melanogaster , 2006, Journal of Comparative Physiology B.
[81] G M Rubin,et al. A brief history of Drosophila's contributions to genome research. , 2000, Science.
[82] Leslie Michels Thompson,et al. A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel Inhibitor , 2003, Neuron.
[83] Michele Vendruscolo,et al. Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity , 2007, PLoS biology.
[84] Peri T Kurshan,et al. Locomotor activity is regulated by D2‐like receptors in Drosophila: An anatomic and functional analysis , 2007, Developmental neurobiology.
[85] C. Nichols,et al. A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain , 2002, Neuropsychopharmacology.
[86] Yves Grau,et al. Glutamate and its metabotropic receptor in Drosophila clock neuron circuits , 2007, The Journal of comparative neurology.
[87] H. Manev,et al. γ-Aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: Adult RNA interference and pharmacological evidence , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[88] H. Rockman,et al. Gene Deletion Screen for Cardiomyopathy in Adult Drosophila Identifies a New Notch Ligand , 2010, Circulation research.
[89] S. Hellberg,et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. , 2009, The Journal of clinical investigation.
[90] J Dausset,et al. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] Michael Simons,et al. Branching morphogenesis. , 2008, Circulation research.
[92] M. Frasch,et al. Genetic and Genomic Dissection of Cardiogenesis in the Drosophila Model , 2010, Pediatric Cardiology.
[93] R. Nusse,et al. Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes , 2002, Science.
[94] M. Zalokar,et al. Permeabilization of Drosophila eggs. , 1973, Developmental biology.
[95] J. Kumar. Retinal determination the beginning of eye development. , 2010, Current topics in developmental biology.
[96] S Lovestone,et al. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.
[97] Jay Hirsh,et al. Stereotypic behavioral responses to free-base cocaine and the development of behavioral sensitization in Drosophila , 1998, Current Biology.
[98] R. Greenspan,et al. Neurohormonal and neuromodulatory control of sleep in Drosophila. , 2007, Cold Spring Harbor symposia on quantitative biology.
[99] Joseph A. Izatt,et al. In Vivo Imaging of the Adult Drosophila melanogaster Heart With Real-Time Optical Coherence Tomography , 2006 .
[100] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[101] K. Furukubo-Tokunaga. Modeling schizophrenia in flies. , 2009, Progress in brain research.
[102] J. Berg. Genome sequence of the nematode C. elegans: a platform for investigating biology. , 1998, Science.
[103] A. Alikaşifoğlu,et al. A Novel Sulfonylurea Receptor Family Member Expressed in the Embryonic Drosophila Dorsal Vessel and Tracheal System* , 1999, The Journal of Biological Chemistry.
[104] N. Silverman,et al. Fighting Infection Fly-Style , 2007, Fly.
[105] Y. Hamasaka,et al. GABA modulates Drosophila circadian clock neurons via GABAB receptors and decreases in calcium. , 2005, Journal of neurobiology.
[106] J. Hoffmann,et al. NF-kappaB in the immune response of Drosophila. , 2009, Cold Spring Harbor perspectives in biology.
[107] Gonçalo R. Abecasis,et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.
[108] E. Rulifson,et al. Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells , 2004, Nature.
[109] David J. Anderson,et al. Two Different Forms of Arousal in Drosophila Are Oppositely Regulated by the Dopamine D1 Receptor Ortholog DopR via Distinct Neural Circuits , 2009, Neuron.
[110] G. Mardon,et al. Whole‐mount analysis reveals normal numbers of dopaminergic neurons following misexpression of α‐Synuclein in Drosophila , 2005, Genesis.
[111] N. Ishida,et al. Circadian Phenotypes of Drosophila Fragile X Mutants in Alternative Genetic Backgrounds , 2008, Zoological science.
[112] H. Lehrach,et al. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[113] Karen Ocorr,et al. A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function , 2010, Cell.
[114] A Jamie,et al. Branching Morphogenesis , 2004 .
[115] Karen Ocorr,et al. Age-related cardiac disease model of Drosophila , 2007, Mechanisms of Ageing and Development.
[116] T. Tully,et al. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl gene , 1992, Neuron.
[117] M Gribskov,et al. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. , 2001, Genome research.
[118] T. Iwatsubo,et al. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.
[119] R. Cagan,et al. Drosophila models for cancer research. , 2006, Current opinion in genetics & development.
[120] Iva Greenwald,et al. Presenilin is required for activity and nuclear access of Notch in Drosophila , 1999, Nature.
[121] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[122] T. Tully,et al. Ethanol Intoxication in Drosophila: Genetic and Pharmacological Evidence for Regulation by the cAMP Signaling Pathway , 1998, Cell.
[123] H. Manev,et al. Drosophila metabolize 1,4-butanediol into γ-hydroxybutyric acid in vivo , 2003 .
[124] A. Schapira,et al. Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant , 2008, European journal of neurology.
[125] M. Goldenberg,et al. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. , 2010, P & T : a peer-reviewed journal for formulary management.
[126] A. Pack,et al. Modafinil maintains waking in the fruit fly drosophila melanogaster. , 2003, Sleep.
[127] D. Nelson,et al. The Drosophila FMRP and LARK RNA-Binding Proteins Function Together to Regulate Eye Development and Circadian Behavior , 2008, The Journal of Neuroscience.
[128] R. Blakely,et al. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α‐synuclein , 2003, Journal of neurochemistry.
[129] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[130] R. Durbin,et al. Analysis of protein domain families in Caenorhabditis elegans. , 1997, Genomics.
[131] Nicholas J Kuklinski,et al. Micellar capillary electrophoresis--electrochemical detection of neurochemicals from Drosophila. , 2010, Journal of separation science.
[132] C. Nichols,et al. Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. , 2006, Pharmacology & therapeutics.
[133] N. Perrimon,et al. Evidence that stem cells reside in the adult Drosophila midgut epithelium , 2006, Nature.
[134] D. Housman,et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.
[135] M. Tsang. Zebrafish: A tool for chemical screens. , 2010, Birth defects research. Part C, Embryo today : reviews.
[136] G. Christofori,et al. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. , 1999, Trends in biochemical sciences.
[137] C. Link,et al. In Vivo Aggregation of β‐Amyloid Peptide Variants , 1998 .
[138] V. Kilman,et al. The GABAA Receptor RDL Acts in Peptidergic PDF Neurons to Promote Sleep in Drosophila , 2009, Current Biology.
[139] Carolyn Hutter,et al. Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis , 2009, American journal of epidemiology.
[140] M. Reith,et al. The importance of company: Na+ and Cl- influence substrate interaction with SLC6 transporters and other proteins. , 2006, Handbook of experimental pharmacology.
[141] Andrew J. Schroeder,et al. Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain , 2002, Neuron.
[142] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[143] Joel Ryan,et al. Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function , 2010, The European journal of neuroscience.
[144] M. Birnbaum,et al. Regulation of Fat Cell Mass by Insulin in Drosophila melanogaster , 2009, Molecular and Cellular Biology.
[145] C. Link,et al. AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model. , 2009, Human molecular genetics.
[146] M. Tanouye,et al. Potassium bromide, an anticonvulsant, is effective at alleviating seizures in the Drosophila bang-sensitive mutant bang senseless , 2004, Brain Research.
[147] Ronald L. Davis,et al. Gene expression systems in Drosophila: a synthesis of time and space. , 2004, Trends in genetics : TIG.
[148] T. Hoppe,et al. A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. , 2005, Human molecular genetics.
[149] K. Caldwell,et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.
[150] Sheng-Ping L. Hwang,et al. Recapitulation of zebrafish sncga expression pattern and labeling the habenular complex in transgenic zebrafish using green fluorescent protein reporter gene , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[151] M. Geyer,et al. Developing translational animal models for symptoms of schizophrenia or bipolar mania , 2008, Neurotoxicity Research.
[152] T. Roeder,et al. Molecular architecture of the fruit fly's airway epithelial immune system , 2008, BMC Genomics.
[153] A. Young,et al. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[154] P. Auluck,et al. Pharmacological prevention of Parkinson disease in Drosophila , 2002, Nature Medicine.
[155] Ann-Shyn Chiang,et al. Specific requirement of NMDA receptors for long-term memory consolidation in Drosophila ellipsoid body , 2007, Nature Neuroscience.
[156] Jian Feng,et al. Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter* , 2004, Journal of Biological Chemistry.
[157] R. Cooper,et al. Monitoring Heart Function in Larval Drosophila melanogaster for Physiological Studies , 2009, Journal of visualized experiments : JoVE.
[158] J. Izatt,et al. Images in cardiovascular medicine: in vivo imaging of the adult Drosophila melanogaster heart with real-time optical coherence tomography. , 2006, Circulation.
[159] J. Dowling,et al. Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[160] M. Konsolaki,et al. A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster , 2004, Molecular and Cellular Neuroscience.
[161] Troy Zars,et al. Serotonin is necessary for place memory in Drosophila , 2008, Proceedings of the National Academy of Sciences.
[162] B. Oostra,et al. Reduction in fragile X related 1 protein causes cardiomyopathy and muscular dystrophy in zebrafish , 2009, Journal of Experimental Biology.
[163] E Sullivan,et al. Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR). , 1999, Methods in molecular biology.
[164] D. Gubb,et al. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. , 2005, Neuroscience.
[165] Qian-Quan Sun,et al. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein , 2007, Neuroscience Letters.
[166] Li Qian,et al. Genetic control of heart function and aging in Drosophila. , 2007, Trends in cardiovascular medicine.
[167] R. Greenspan,et al. Where Can I Find out More? , 2022 .
[168] S. Lovestone,et al. Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions , 2005, Neurobiology of Disease.
[169] C. Nichols. 5‐HT2 receptors in Drosophila are expressed in the brain and modulate aspects of circadian behaviors , 2007, Developmental neurobiology.
[170] S. Haggarty,et al. Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.
[171] J. Taylor,et al. Flightless flies: Drosophila models of neuromuscular disease , 2010, Annals of the New York Academy of Sciences.
[172] H. Richardson,et al. Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module , 2008, Oncogene.
[173] Thomas Roeder,et al. Drosophila in asthma research. , 2009, American journal of respiratory and critical care medicine.
[174] Tian Xu,et al. A Genetic Screen in Drosophila for Metastatic Behavior , 2003, Science.
[175] J. Januschke,et al. Drosophila asymmetric division, polarity and cancer , 2008, Oncogene.
[176] H. Jäckle,et al. Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.
[177] M Lappé,et al. Genetic control. , 1972, The New England journal of medicine.
[178] M. Tanouye,et al. Seizure suppression by shakB2, a gap junction mutation in Drosophila. , 2006, Journal of neurophysiology.
[179] D. Rubinsztein,et al. Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish , 2008, The Journal of Neuroscience.
[180] Hugo J. Bellen,et al. 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future , 2010, Nature Reviews Neuroscience.
[181] R. Richards,et al. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. , 2007, Human molecular genetics.
[182] A. Sehgal,et al. Identification of SLEEPLESS, a Sleep-Promoting Factor , 2008, Science.
[183] Tim Tully,et al. CREB and the discovery of cognitive enhancers , 2002, Journal of Molecular Neuroscience.
[184] M. Fortini,et al. Modeling Clinically Heterogeneous Presenilin Mutations with Transgenic Drosophila , 2006, Current Biology.
[185] R. Cripps,et al. Cardiac gene regulatory networks in Drosophila. , 2009, Biochimica et biophysica acta.
[186] G. Rubin,et al. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase , 1991, Cell.
[187] R. Plasterk,et al. APL-1, a Caenorhabditis elegans protein related to the human β-amyloid precursor protein, is essential for viability , 2007, Proceedings of the National Academy of Sciences.
[188] S. Benzer,et al. Prandiology of Drosophila and the CAFE assay , 2007, Proceedings of the National Academy of Sciences.
[189] R. Blakely,et al. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6‐hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking , 2005, Journal of neurochemistry.
[190] U. Heberlein,et al. Drugs, flies, and videotape: the effects of ethanol and cocaine on Drosophila locomotion , 2002, Current Opinion in Neurobiology.
[191] S. Pimplikar,et al. Amyloid precursor protein is required for convergent-extension movements during Zebrafish development. , 2009, Developmental biology.
[192] K. Ocorr,et al. Visualizing the beating heart in Drosophila. , 2009, Journal of visualized experiments : JoVE.
[193] Simon C Watkins,et al. Generation of FGF reporter transgenic zebrafish and their utility in chemical screens , 2007, BMC Developmental Biology.
[194] U. Heberlein,et al. Invertebrate models of drug abuse. , 2003, Journal of neurobiology.
[195] S. Benzer,et al. Development of the Drosophila retina, a neurocrystalline lattice. , 1976, Developmental biology.
[196] C. Klämbt,et al. Organization and Function of the Blood–Brain Barrier in Drosophila , 2008, The Journal of Neuroscience.
[197] J. Taylor,et al. Dynein light chain 1 is required for autophagy, protein clearance, and cell death in Drosophila , 2009, Proceedings of the National Academy of Sciences.
[198] Richard M. Page,et al. Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease , 2005, Neuroscience.
[199] G. Tononi,et al. Correlates of sleep and waking in Drosophila melanogaster. , 2000, Science.
[200] N. Perrimon,et al. γ‐Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[201] Nobutaka Hattori,et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. , 2005, Human molecular genetics.
[202] J. Trojanowski,et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.
[203] A. Woollard,et al. RUNX factors in development: lessons from invertebrate model systems. , 2009, Blood cells, molecules & diseases.
[204] Laura Feeney,et al. Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitive mutants. , 2004, Journal of neurobiology.
[205] J. Hirsh,et al. Roles of Dopamine in Circadian Rhythmicity and Extreme Light Sensitivity of Circadian Entrainment , 2010, Current Biology.
[206] G. Torres,et al. Activating properties of cocaine and cocaethylene in a behavioral preparation of Drosophila melanogaster , 1998, Synapse.
[207] D. Campion,et al. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein , 2010, Journal of neurochemistry.
[208] Oliver Bandmann,et al. Genetic zebrafish models of neurodegenerative diseases , 2010, Neurobiology of Disease.
[209] Peter G. Schultz,et al. High-Throughput Chemical Screen Identifies a Novel Potent Modulator of Cellular Circadian Rhythms and Reveals CKIα as a Clock Regulatory Kinase , 2010, PLoS biology.
[210] E. Rulifson,et al. The origin of islet-like cells in Drosophila identifies parallels to the vertebrate endocrine axis , 2007, Proceedings of the National Academy of Sciences.
[211] G. Gibson,et al. Genetic Variation for Cardiac Dysfunction in Drosophila , 2007, PloS one.
[212] K. Ocorr,et al. Fluorescent labeling of Drosophila heart structures. , 2009, Journal of visualized experiments : JoVE.
[213] M. Fortini,et al. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants , 1999, Nature.
[214] U. Langheinrich,et al. Zebrafish: a new model on the pharmaceutical catwalk. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[215] Y. Christen,et al. Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans , 2006, The Journal of Neuroscience.
[216] J. Hoffmann,et al. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections , 2007, Nature Reviews Immunology.
[217] J. Lazo,et al. Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z , 2010, PloS one.
[218] J. Dubnau,et al. Deconstructing Memory in Drosophila , 2005, Current Biology.
[219] P. Jin,et al. Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia Syndrome , 2007, Neuron.
[220] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[221] R. Cagan,et al. The emergence of order in the Drosophila pupal retina. , 1989, Developmental biology.
[222] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[223] T. Tabata,et al. Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila , 2002, Neuron.
[224] Michael Lardelli,et al. Zebrafish as a tool in Alzheimer's disease research. , 2011, Biochimica et biophysica acta.
[225] R. Morimoto,et al. Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-Specific Aggregation in a Pan-Neuronal Caenorhabditis elegans Model , 2006, The Journal of Neuroscience.
[226] N. Perrimon,et al. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. , 1993, Development.
[227] Pietro Perona,et al. High-throughput Ethomics in Large Groups of Drosophila , 2009, Nature Methods.
[228] Ronald W. Davis,et al. High-Resolution, In Vivo Magnetic Resonance Imaging of Drosophila at 18.8 Tesla , 2008, PloS one.
[229] M. Lardelli,et al. Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. , 2003, Experimental cell research.
[230] David H. Hall,et al. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[231] Aaron J. Bell,et al. Age-dependent cognitive impairment in a Drosophila Fragile X model and its pharmacological rescue , 2010, Biogerontology.
[232] M. Zeidler,et al. Transcriptional targets of Drosophila JAK/STAT pathway signalling as effectors of haematopoietic tumour formation , 2010, EMBO reports.
[233] U. Heberlein,et al. Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila , 2000, Current Biology.
[234] Christian Néri,et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons , 2005, Nature Genetics.
[235] W. A. Johnson,et al. Drosophila DEG/ENaC pickpocket genes are expressed in the tracheal system, where they may be involved in liquid clearance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[236] J. Taylor,et al. Repeat expansion disease: progress and puzzles in disease pathogenesis , 2010, Nature Reviews Genetics.
[237] A Dürr,et al. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[238] H. Rockman,et al. Drosophila melanogaster as a model system for genetics of postnatal cardiac function. , 2008, Drug discovery today. Disease models.
[239] W. Neckameyer. A Trophic Role for Serotonin in the Development of a Simple Feeding Circuit , 2010, Developmental Neuroscience.
[240] S. Hyman,et al. Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.
[241] Jisue Lee,et al. Electroconvulsive Seizure Behavior in Drosophila: Analysis of the Physiological Repertoire Underlying a Stereotyped Action Pattern in Bang-Sensitive Mutants , 2002, The Journal of Neuroscience.
[242] C. Ross,et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[243] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.
[244] S. Birman,et al. Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster , 2004, The Journal of Neuroscience.
[245] Rebecca B. Smith,et al. Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy , 2010, Neuron.
[246] T. Nakajima,et al. [Serotonin (5-HT)]. , 1978, Nihon rinsho. Japanese journal of clinical medicine.
[247] C. Ross,et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity , 2006, Nature Neuroscience.
[248] Shamik Dasgupta,et al. A Neural Circuit Mechanism Integrating Motivational State with Memory Expression in Drosophila , 2009, Cell.
[249] J. Abrams,et al. Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila , 2003, Oncogene.
[250] Lili Wan,et al. Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein , 2000, Molecular and Cellular Biology.
[251] Chiara Cirelli,et al. The genetic and molecular regulation of sleep: from fruit flies to humans , 2009, Nature Reviews Neuroscience.
[252] Ralph J Greenspan,et al. Serotonin and neuropeptide F have opposite modulatory effects on fly aggression , 2007, Nature Genetics.
[253] Gerald M. Rubin,et al. Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function , 2001, Cell.
[254] S. Waddell. Dopamine reveals neural circuit mechanisms of fly memory , 2010, Trends in Neurosciences.
[255] S. Röhrig,et al. Presenilin is required for proper morphology and function of neurons in C. elegans , 2000, Nature.
[256] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[257] C. Nichols,et al. Serotonin 5-HT2 and 5-HT1A-like receptors differentially modulate aggressive behaviors in Drosophila melanogaster , 2009, Neuroscience.
[258] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[259] Pietro Perona,et al. Automated monitoring and analysis of social behavior in Drosophila , 2009, Nature Methods.
[260] P. Krogsgaard‐Larsen,et al. GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. , 2000, Current pharmaceutical design.
[261] K. Gengyo-Ando,et al. Progressive neurodegeneration in C. elegans model of tauopathy , 2005, Neurobiology of Disease.
[262] N. Trede,et al. Immunology and zebrafish: spawning new models of human disease. , 2008, Developmental and comparative immunology.
[263] B. Ganetzky,et al. Indirect Suppression Involving Behavioral Mutants with Altered Nerve Excitability in DROSOPHILA MELANOGASTER. , 1982, Genetics.
[264] B. Dickson,et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila , 2007, Nature.
[265] J. Whitten. The Post-embryonic Development of the Tracheal System in Drosophila melanogaster , 1957 .
[266] M. Rand,et al. Drosophotoxicology: the growing potential for Drosophila in neurotoxicology. , 2010, Neurotoxicology and teratology.
[267] W. Quinn,et al. Classical conditioning and retention in normal and mutantDrosophila melanogaster , 1985, Journal of Comparative Physiology A.
[268] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[269] J. Ronesi,et al. Hallucinogens and Drosophila: linking serotonin receptor activation to behavior , 2002, Neuroscience.
[270] R. Pulak,et al. Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. , 2006, Methods in molecular biology.
[271] N. Franceschini,et al. Les phénomènes de pseudopupille dans l'œil composé deDrosophila , 1971, Kybernetik.
[272] Xiangzhong Zheng,et al. Serotonin Modulates Circadian Entrainment in Drosophila , 2005, Neuron.
[273] C. Link,et al. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[274] E. Pehek,et al. Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegans , 2010, PloS one.
[275] P. Verstreken,et al. Suppression of Neurodegeneration and Increased Neurotransmission Caused by Expanded Full-Length Huntingtin Accumulating in the Cytoplasm , 2008, Neuron.
[276] Adrian Bradu,et al. Dual optical coherence tomography/fluorescence microscopy for monitoring of Drosophila melanogaster larval heart. , 2009, Journal of biophotonics.
[277] Darren W. Williams,et al. Tau and tau reporters disrupt central projections of sensory neurons in Drosophila , 2000, The Journal of comparative neurology.
[278] D. Butterfield,et al. Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model , 2003, Neurobiology of Aging.
[279] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[280] G. Mardon,et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.
[281] N. Hattori,et al. Pathogenetic mechanisms of parkin in Parkinson's disease , 2004, The Lancet.
[282] M. MacDonald,et al. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[283] T. Johnson,et al. Paralogy and orthology of tyrosine kinases that can extend the life span of Caenorhabditis elegans. , 2000, Molecular biology and evolution.
[284] E. Wanker,et al. Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease , 2006, Neurobiology of Disease.
[285] R. Richards,et al. Selective neuronal requirement for huntingtin in the developing zebrafish , 2009, Human molecular genetics.